Royal Philips scores 48/100 (Making progress) on SINK's independent climate assessment — scored from public data only, no company payment can change a number. Last verified May 2026.
That places Royal Philips joint 133rd of 691 companies scored, and joint 8th of 15 in Healthcare / Pharmaceuticals.
Philips demonstrates strong climate governance with SBTi-validated targets, 80% renewable energy, and A-list CDP scores across 11 years. However, operational emissions rose 5.81% in 2024, Scope 3 remains 537% above 2018 levels, and a massive product safety recall with ongoing DOJ/SEC scrutiny severely undermines credibility.
This score is built from public data only. If your practice is stronger than your disclosure, submit evidence for review — or challenge any question, free.
Same ten questions for every company. No private weighting.
SINK = (0.3 × Base + 0.7 × Performance) × ScaleStrongest on Carbon Footprint — Operations and Transparency & Accountability (8/10, 8/10). Weakest on Controversies & Red Flags and Nature & Biodiversity Impact (4/10, 5/10).
18 sources used in this assessment. All publicly available. Each row shows which rubric questions it informed.
12 of 18 sources are third-party verified or public record.
If you believe a source has been misread or a newer version exists, submit a challenge.
Where Royal Philips sits among healthcare / pharmaceuticals peers.
Among the 15 major healthcare / pharmaceuticals brands we've scored, Royal Philips is tied =8th of 15, with 1 other.
Score history begins 11 April 2026.
As Royal Philips's score updates, the trajectory will appear here.
We're backfilling historical scores for FTSE 100 and S&P 100 companies over the coming weeks.
This score is not currently being contested.
Every challenge is published. We'd rather be corrected than wrong — that's the whole point.
No challenges submitted yet. If you have evidence that contradicts this score, you can challenge any question above — cite a public source and we'll review it.
Royal Philips is a Dutch healthcare and electronics conglomerate founded in 1891, headquartered in Amsterdam. The company manufactures medical devices, diagnostic imaging systems, patient monitoring equipment, and consumer health products. With 81,592 employees and €17.2 billion annual revenue, Philips ranks among Europe's largest diversified industrial manufacturers.
Large diversified industrial conglomerate with parallel climate targets and product safety audit challenges.
View breakdown →Healthcare and industrial equipment manufacturer; comparable scale and regulatory scrutiny in medical device domains.
View breakdown →Major healthcare multinational with extensive ESG reporting and ongoing product liability litigation legacy.
View breakdown →Swiss pharmaceutical and diagnostics peer; comparable SBTi commitments and supply-chain carbon transparency standards.
View breakdown →Email alerts when a rubric question is verified, a challenge is resolved, or the overall score changes.
One email, every Sunday. Score changes, new research, the stories behind the numbers. Free.
No spam. Unsubscribe in one click.
Checking a company?
Search free →Been scored?
See what's behind your number →Nobody can pay us to change a number.